>>15582627 (Previous notable) - Jeremy Farrar's Congressional Testimony

The might also be a Barry/Honey Sherman connection - was digging on them, and Apotex and found this

Posted on August 27, 2013

A one-time-only combination: Emergency medicine exports under Canada’s access to medicines regime

At first glance, the process may appear straightforward, but as Apotex found, when the drug involves more than one patent, negotiations can become extremely complicated and time-consuming. In the case of Apo-TriAvir, the GlaxoSmithKline, the Wellcome Foundation, Shire Biochemical, and Boehringer Ingelheim Pharmaceuticals owned relevant patents; three of these firms were not prepared to issue a voluntary license without further conditions

These factors include the commitment of the generic manufacturer Apotex; the cooperation of MSF, the Clinton Foundation, and Canadian regulatory agencies;

https://www.hhrjournal.org/2013/08/a-one-time-only-combination-emergency-medicine-exports-under-canadas-access-to-medicines-regime/